Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Placebo-controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy
the DEMAND V study group
Neurology
Research output
:
Contribution to journal
›
Article
›
peer-review
26
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Placebo-controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
PRO051
100%
Duchenne Muscular Dystrophy
55%
Placebos
32%
Walking
20%
Injection Site Reaction
8%
Respiratory Function Tests
6%
Muscle Strength
6%
Proteinuria
5%
Half-Life
5%
Pharmacokinetics
4%
Safety
3%
Therapeutics
2%